Arrowstreet Capital
WVE icon

Arrowstreet Capital’s Wave Life Sciences WVE Stock Holding History

Arrowstreet Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-113,840
Closed -$702K – 1810
2024
Q1 		$702K Buy
+113,840
New +$570K ﹤0.01% 1389
2020
Q3 		– Sell
-139,877
Closed -$1.46M – 2545
2020
Q2 		$1.46M Buy
+139,877
New +$1.32M ﹤0.01% 1612
2018
Q4 		– Sell
-8,000
Closed -$400K – 1530
2018
Q3 		$400K Buy
+8,000
New +$361K ﹤0.01% 931

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Arrowstreet Capital's WVE Position: Q2 2024 in Review

Arrowstreet Capital sold out of Wave Life Sciences (WVE) in Q2 2024, closing a stake of 113,840 shares — an estimated $702K sold.

Arrowstreet Capital first reported a position in WVE in Q3 2018 and held it in 3 quarters. The position peaked at $1.46M in Q2 2020. 144 funds tracked by Wall St. Rank hold WVE as of Q2 2024.

  • Arrowstreet Capital reported no remaining Wave Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Arrowstreet Capital sold 113,840 Wave Life Sciences shares in Q2 2024, an estimated $702K.
  • Arrowstreet Capital first reported a position in Wave Life Sciences in Q3 2018 and held it in 3 quarters.
  • Arrowstreet Capital's Wave Life Sciences position peaked at $1.46M in Q2 2020.
  • 144 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2024.

Based on Arrowstreet Capital's 13F filing for Q2 2024, filed 14 Aug 2024.